These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 1359109)
21. The pharmacological characterization of a novel selective 5-hydroxytryptamine1A receptor antagonist, NAD-299. Johansson L; Sohn D; Thorberg SO; Jackson DM; Kelder D; Larsson LG; Rényi L; Ross SB; Wallsten C; Eriksson H; Hu PS; Jerning E; Mohell N; Westlind-Danielsson A J Pharmacol Exp Ther; 1997 Oct; 283(1):216-25. PubMed ID: 9336327 [TBL] [Abstract][Full Text] [Related]
22. Differential interactions of "prosexual" drugs with 5-hydroxytryptamine1A and alpha 2-adrenergic receptors. Kwong LL; Smith ER; Davidson JM; Peroutka SJ Behav Neurosci; 1986 Oct; 100(5):664-8. PubMed ID: 2877677 [TBL] [Abstract][Full Text] [Related]
23. [3H]5-methyl-urapidil labels 5-HT1A receptors and alpha 1-adrenoceptors in the rat CNS. In vitro binding and autoradiographic studies. Laporte AM; Schechter LE; Bolaños FJ; Vergé D; Hamon M; Gozlan H Eur J Pharmacol; 1991 May; 198(1):59-67. PubMed ID: 1680714 [TBL] [Abstract][Full Text] [Related]
24. Actions of alpha2 adrenoceptor ligands at alpha2A and 5-HT1A receptors: the antagonist, atipamezole, and the agonist, dexmedetomidine, are highly selective for alpha2A adrenoceptors. Newman-Tancredi A; Nicolas JP; Audinot V; Gavaudan S; Verrièle L; Touzard M; Chaput C; Richard N; Millan MJ Naunyn Schmiedebergs Arch Pharmacol; 1998 Aug; 358(2):197-206. PubMed ID: 9750005 [TBL] [Abstract][Full Text] [Related]
25. [3H]rauwolscine behaves as an agonist for the 5-HT1A receptors in human frontal cortex membranes. De Vos H; Czerwiec E; De Backer JP; De Potter W; Vauquelin G Eur J Pharmacol; 1991 May; 207(1):1-8. PubMed ID: 1680719 [TBL] [Abstract][Full Text] [Related]
26. Adrenoceptors and dopamine receptors are not involved in the discriminative stimulus effect of the 5-HT1A receptor agonist flesinoxan. Ybema CE; Olivier B; Mos J; Tulp MT; Slangen JL Eur J Pharmacol; 1994 Apr; 256(2):141-7. PubMed ID: 8050464 [TBL] [Abstract][Full Text] [Related]
27. Modulation of sexual behaviour in the rat by a potent and selective alpha 2-adrenoceptor antagonist, delequamine (RS-15385-197). Tallentire D; McRae G; Spedding M; Clark R; Vickery B Br J Pharmacol; 1996 May; 118(1):63-72. PubMed ID: 8733577 [TBL] [Abstract][Full Text] [Related]
28. Partial agonist properties of rauwolscine and yohimbine for the inhibition of adenylyl cyclase by recombinant human 5-HT1A receptors. Arthur JM; Casañas SJ; Raymond JR Biochem Pharmacol; 1993 Jun; 45(11):2337-41. PubMed ID: 8517875 [TBL] [Abstract][Full Text] [Related]
29. Discriminative stimulus properties of 8-OH-DPAT: relationship to affinity for 5HT1A receptors. Sanger DJ; Schoemaker H Psychopharmacology (Berl); 1992; 108(1-2):85-92. PubMed ID: 1357711 [TBL] [Abstract][Full Text] [Related]
31. The subtype-selective alpha 2-adrenoceptor antagonists BRL 44408 and ARC 239 also recognize 5-HT1A receptors in the rat brain. Meana JJ; Callado LF; Pazos A; Grijalba B; García-Sevilla JA Eur J Pharmacol; 1996 Oct; 312(3):385-8. PubMed ID: 8894622 [TBL] [Abstract][Full Text] [Related]
32. Alpha 2 receptors mediate the antinociceptive action of 8-OH-DPAT in the hot-plate test in mice. Millan MJ; Colpaert FC Brain Res; 1991 Jan; 539(2):342-6. PubMed ID: 1675912 [TBL] [Abstract][Full Text] [Related]
33. Evaluation of the effects of a specific alpha 2-adrenoceptor antagonist, atipamezole, on alpha 1- and alpha 2-adrenoceptor subtype binding, brain neurochemistry and behaviour in comparison with yohimbine. Haapalinna A; Viitamaa T; MacDonald E; Savola JM; Tuomisto L; Virtanen R; Heinonen E Naunyn Schmiedebergs Arch Pharmacol; 1997 Nov; 356(5):570-82. PubMed ID: 9402036 [TBL] [Abstract][Full Text] [Related]
34. Vasodilatation elicited by 5-HT1A receptor agonists in constant-pressure-perfused rat kidney is mediated by blockade of alpha 1A-adrenoceptors. Eltze M; Boer R; Sanders KH; Kolassa N Eur J Pharmacol; 1991 Sep; 202(1):33-44. PubMed ID: 1686254 [TBL] [Abstract][Full Text] [Related]
35. Discriminative stimulus effect of flesinoxan: effect of 5-HT1A antagonists and PCPA. Ybema CE; Slangen JL; Olivier B Pharmacol Biochem Behav; 1994 Apr; 47(4):957-62. PubMed ID: 8029269 [TBL] [Abstract][Full Text] [Related]
36. Effect of the putative 5-HT1A receptor antagonist NAN-190 on rat brain serotonergic transmission. Claustre Y; Rouquier L; Serrano A; Bénavidès J; Scatton B Eur J Pharmacol; 1991 Oct; 204(1):71-7. PubMed ID: 1666563 [TBL] [Abstract][Full Text] [Related]
37. Modulation of postdecapitation convulsions in rats by alpha-adrenergic and 5-hydroxytryptamine1A agents. Peroutka SJ; Gonzales DA; Shapiro M Exp Neurol; 1987 May; 96(2):344-51. PubMed ID: 2883018 [TBL] [Abstract][Full Text] [Related]
38. Decrease in gastric sensitivity to distension by 5-HT1A receptor agonists in rats. Rouzade ML; Fioramonti J; Bueno L Dig Dis Sci; 1998 Sep; 43(9):2048-54. PubMed ID: 9753272 [TBL] [Abstract][Full Text] [Related]
39. Involvement of 5-HT1A activity in the discriminative stimulus effects of imipramine. Barrett JE; Zhang L Pharmacol Biochem Behav; 1991 Feb; 38(2):407-10. PubMed ID: 1829231 [TBL] [Abstract][Full Text] [Related]
40. Sympatholytic action of yohimbine mediated by 5-HT1A receptors. McCall RB; Harris LT; King KA Eur J Pharmacol; 1991 Jun; 199(2):263-5. PubMed ID: 1683291 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]